Navigation Links
Whole Gel Eluter Purification of a Functional Multiprotein DNA Replication Complex, Rev A

IN VITRO SV40 REPLICATION ASSAY
The assay was performed essentially as described in Malkas et al.2


Results
THE WHOLE GEL ELUTER CAN RAPIDLY AND EFFICIENTLY ELECTRO-ELUTE HIGH MOLECULAR WEIGHT PROTEIN COMPLEXES FROM NATIVE PAGE GELS
We have previously found that when the replicationcompetent DNA synthesome protein fraction, purified from human cells as outlined in Figure 1, was subjected to native PAGE, several distinct high molecular weight protein species were observed.7 An example of a silver stained native PAGE resolution of the DNA synthesome protein fraction is shown in Figure 2, lane 5. We have recently identified the specific high molecular weight protein band that contains the fully functional DNA synthesome (Tom et al., to be published elsewhere). The high molecular weight DNA synthesome protein band is indicated by an arrow in Figure 2, lane 5. The initial identification of the discrete DNA synthesome protein band in the native PAGE (Tom et al., to be published elsewhere) required the time consuming procedure of first cutting the gel into small pieces that were then each individually placed into dialysis tubing and the synthesome protein subsequently electro-eluted from the gel using standard methods.10 This tedious process of obtaining highly purified forms of the DNA synthesome from native PAGE has recently been greatly facilitated by the incorporation of the Whole Gel Eluter into the purification protocol.

The DNA synthesome protein fraction was derived using the procedure outlined in Figure 1. The protein fraction was then resolved by native PAGE as described in the Methods. The native gel
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Fast and Easy Isolation of PCR-Ready Genomic DNA from Whole Blood
2. Protocol for GenomePlex Whole Genome Amplification from Buccal Swab
3. Protocol for GenomePlex Whole Genome Amplification from Blood Card
4. Protocol for GenomePlex Whole Genome Amplification from Plant
5. Protocol for GenomePlex Whole Genome Amplification from Soil
6. Protocol for GenomePlex Whole Genome Amplification from Whole Blood
7. Protocol for GenomePlex Whole Genome Amplification from Formalin-Fixed Parrafin-Embedded (FFPE) tissue
8. Bacterial Whole Genome Array Analysis
9. RNAi: Get the Whole Story
10. Total RNA from Whole Blood for Expression Profiling
11. Fractionation of Bovicola ovis Homogenates Using the Mini Whole Gel Eluter
Post Your Comments:
Breaking Biology Technology:AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5AEterna Zentaris Partner, Keryx, Reports Updated Phase 1/2 Data, Including New Survival Data, on Perifosine (KRX-0401) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 2ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 3ATS Medical Announces CE Mark Approval for the ATS 3f Enable Bioprosthesis 4AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 2AEterna Zentaris Announces Results from its European Phase 3 Study with Cetrorelix in Benign Prostatic Hyperplasia 3Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 2Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 3